IMAX (NYSE:IMAX) Price Target Raised to $54.00

IMAX (NYSE:IMAX) had its target price boosted by Wedbush from $46.00 to $54.00 in a research note issued to investors on Friday, Marketbeat Ratings reports. Wedbush currently has an outperform rating on the stock.

Other analysts also recently issued reports about the stock. Weiss Ratings upgraded shares of IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, July 16th. Keefe, Bruyette & Woods reiterated a “market perform” rating and set a $60.00 price objective on shares of IMAX in a research note on Friday, May 22nd. B. Riley Financial raised their price objective on shares of IMAX from $48.00 to $52.00 and gave the company a “buy” rating in a research note on Monday, July 20th. JPMorgan Chase & Co. dropped their target price on IMAX from $48.00 to $47.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Finally, Barrington Research upped their target price on IMAX from $42.00 to $46.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Ten analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $50.36.

IMAX Price Performance

Shares of IMAX stock opened at $43.21 on Friday. IMAX has a 1-year low of $24.20 and a 1-year high of $45.88. The business’s fifty day moving average price is $39.99 and its two-hundred day moving average price is $38.05. The company has a market capitalization of $2.37 billion, a P/E ratio of 60.02, a PEG ratio of 1.59 and a beta of 0.37.

IMAX (NYSE:IMAX) last released its quarterly earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.13. IMAX had a return on equity of 15.47% and a net margin of 9.84%.The company had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $96.09 million. During the same quarter in the prior year, the business posted $0.26 earnings per share. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, research analysts expect that IMAX will post 1.3 earnings per share for the current fiscal year.

Hedge Funds Weigh In On IMAX

Large investors have recently made changes to their positions in the business. Orbis Allan Gray Ltd lifted its stake in IMAX by 31.7% during the second quarter. Orbis Allan Gray Ltd now owns 5,113,033 shares of the company’s stock valued at $142,960,000 after purchasing an additional 1,230,267 shares during the last quarter. Westfield Capital Management Co. LP grew its position in IMAX by 44.6% in the fourth quarter. Westfield Capital Management Co. LP now owns 2,346,486 shares of the company’s stock worth $86,726,000 after buying an additional 723,861 shares during the last quarter. Marsico Capital Management LLC acquired a new position in IMAX in the fourth quarter worth approximately $18,149,000. Balyasny Asset Management L.P. bought a new position in shares of IMAX in the second quarter valued at $12,568,000. Finally, Nuveen LLC increased its holdings in shares of IMAX by 253.0% in the fourth quarter. Nuveen LLC now owns 507,377 shares of the company’s stock valued at $18,753,000 after buying an additional 363,658 shares in the last quarter. Institutional investors own 93.51% of the company’s stock.

IMAX News Roundup

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX reported better-than-expected second-quarter results, with EPS and revenue both topping Wall Street estimates, while management reaffirmed full-year guidance and highlighted margin expansion and network growth. IMAX Corporation Reports Second Quarter 2026 Results
• Positive Sentiment: Strong box-office traction for The Odyssey is boosting confidence that IMAX can sustain higher ticket sales and premium-screen utilization, with reports suggesting the film could be a transformational release for the company. The Odyssey is cleaning up for IMAX. Expect the momentum to continue
• Positive Sentiment: Analysts turned more bullish after earnings, with JPMorgan, Wells Fargo, Barrington, and Wedbush all raising price targets, and Wedbush reiterating Outperform on expectations for a stronger film pipeline, market-share gains, and international expansion. IMAX price target boosted by Wedbush on growth outlook
• Positive Sentiment: Investor attention is also being reinforced by unusual call-option activity and multiple stories about sold-out IMAX 70mm showings, signaling strong near-term demand sentiment around the stock. Imax’s CEO says it’s time to hike prices as tickets to ‘The Odyssey’ resell for $1,000
• Neutral Sentiment: IMAX disclosed a new regulatory risk tied to geopolitical, trade, and other global expansion challenges, which could matter over time but does not appear to be driving near-term trading. IMAX Confronts Rising Geopolitical, Regulatory and Trade Risks Threatening Global Expansion

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.